首页>投融资
Aqemia
未公开
Aqemia is a next-gen pharmatech company that discovers drug technology for critical diseases with physics and artificial intelligence.In October 2022, Aqemia raises €30 million in a Series A funding round led by Eurazeo and EPIC Bpifrance through its Large Venture fund, with the participation of Elaia its historic investor
基本信息
-
公司全称Aqemia
-
类型创新药物开发商
-
产业领域医疗信息化、AI+辅助诊断
-
公司人数15~50人
-
地址231 Rue Saint Honore Paris 1 PARIS ILE-DE-FRANCE 75001; FR;
-
联系电话
-
邮箱contact@aqemia.com
-
成立时间2019-06-13
投融资
-
2024-12-10未公开3800万美元Cathay InnovationBpifranceWendel GrowthEurazeoElaia Partners
-
2024-01-30A轮3000万欧元Wendel GrowthLarge VentureElaiaEurazeo
-
2024-01-30A轮3000万欧元Wendel GrowthBpifranceEurazeoElaia Partners
-
2022-10-19A轮3000万欧元BpifranceEurazeo
-
2022-10-19A轮3000万欧元EurazeoBpifrance
-
2019-10-17A轮100万欧元Elaia
-
2019-10-17A轮100万欧元Elaia Partners
- 加载更多
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息